AnaptysBio First Tracks Biotherapeutics

Summary

AnaptysBio is spinning off its early-stage pipeline assets into First Tracks Biotherapeutics, allowing the parent to focus on its lead clinical programs while giving the SpinCo independent access to capital markets.